Cardinal Health, Inc. (CAH) EBITDA Margin: 1.40%
Is Cardinal Health, Inc.’s EBITDA margin high or low?
Cardinal Health, Inc.'s EBITDA margin of 1.40% is 306% above its 5-year average of 0.34%, near the high end of its 5-year range (-1.71%–1.40%).
As of Monday, June 15, 2026. 23.89% above its 12-month average of 1.13%.
CAH EBITDA Margin Chart
CAH Average EBITDA Margin Chart
CAH Current vs Average EBITDA Margin Chart
CAH EBITDA Margin Metrics
EBITDA MARGIN
1.40%
EBITDA MARGIN AVG TTM
1.13%
EBITDA MARGIN AVG 3Y
0.75%
EBITDA MARGIN AVG 5Y
0.34%
EBITDA MARGIN AVG 10Y
1.11%
EBITDA MARGIN AVG 15Y
1.56%
EBITDA MARGIN AVG 20Y
1.75%
CURRENT VS TTM AVG
+23.89%
CURRENT VS 3Y AVG
+87.29%
CURRENT VS 5Y AVG
+305.80%
CURRENT VS 10Y AVG
+25.92%
CURRENT VS 15Y AVG
-10.22%
CURRENT VS 20Y AVG
-19.86%
CAH Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $52.43B | 1.40% | 1.13% | 0.75% | 0.34% |
| Becton, Dickinson and Company (BDX)vs › | $52.98B | 22.70% | 23.29% | 23.17% | 22.44% |
| Cencora, Inc. (COR)vs › | $54.80B | 1.16% | 1.15% | 1.23% | 0.63% |
| Humana Inc. (HUM)vs › | $45.53B | 2.24% | 2.50% | 3.66% | 4.53% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.24B | 34.13% | 33.43% | 32.56% | 31.99% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $63.06B | 40.57% | 39.01% | 39.25% | 44.24% |
| Agilent Technologies, Inc. (A)vs › | $36.67B | 26.41% | 27.60% | 26.98% | 26.47% |
| Zoetis Inc. (ZTS)vs › | $33.36B | 42.98% | 42.41% | 42.38% | 41.76% |
| Centene Corporation (CNC)vs › | $32.19B | -2.64% | 0.58% | 1.90% | 2.49% |
| Medline Inc. (MDLN)vs › | $30.96B | 6.87% | 10.36% | 10.13% | 10.13% |
Margin Comparison
Gross Margin
3.7%
EBITDA Margin
1.4%
Operating Margin
0.9%
Net Margin
0.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
Cardinal Health, Inc. EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cardinal Health, Inc. EBITDA Margin FAQ
- What is the EBITDA margin for Cardinal Health, Inc. (CAH)?
- The EBITDA margin for CAH stock is 1.40%.
- Is Cardinal Health, Inc.'s EBITDA margin high or low?
- Cardinal Health, Inc.'s EBITDA margin of 1.40% is 306% above its 5-year average of 0.34%, near the high end of its 5-year range (-1.71%–1.40%).
- What is the TTM average EBITDA margin for Cardinal Health, Inc. (CAH)?
- The TTM average EBITDA margin for CAH stock is 1.13%.
- What is the 3Y average EBITDA margin for Cardinal Health, Inc. (CAH)?
- The 3Y average EBITDA margin for CAH stock is 0.75%.
- What is the 5Y average EBITDA margin for Cardinal Health, Inc. (CAH)?
- The 5Y average EBITDA margin for CAH stock is 0.34%.
- What is the 10Y average EBITDA margin for Cardinal Health, Inc. (CAH)?
- The 10Y average EBITDA margin for CAH stock is 1.11%.
- What is the 15Y average EBITDA margin for Cardinal Health, Inc. (CAH)?
- The 15Y average EBITDA margin for CAH stock is 1.56%.
- What is the 20Y average EBITDA margin for Cardinal Health, Inc. (CAH)?
- The 20Y average EBITDA margin for CAH stock is 1.75%.
Cardinal Health, Inc. EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-06-30 | 1.40% |
| 2024-06-30 | 0.86% |
| 2023-06-30 | 0.70% |
| 2022-06-30 | 0.03% |
| 2021-06-30 | 0.79% |
| 2020-06-30 | -1.71% |
| 2019-06-30 | 2.09% |
| 2018-06-30 | 0.83% |
| 2017-06-30 | 2.19% |
| 2016-06-30 | 2.55% |
| 2015-06-30 | 2.50% |
| 2014-06-30 | 2.62% |
| 2013-06-30 | 1.39% |
| 2012-06-30 | 1.97% |
| 2011-06-30 | 1.87% |
| 2010-06-30 | 1.60% |
| 2009-06-30 | 1.71% |
| 2008-06-30 | 1.90% |
| 2007-06-30 | 2.12% |
| 2006-06-30 | 2.78% |
| 2005-06-30 | 3.04% |
| 2004-06-30 | 4.18% |
| 2003-06-30 | 4.57% |
| 2002-06-30 | 4.32% |
| 2001-06-30 | 3.69% |
| 2000-06-30 | 4.01% |
| 1999-06-30 | 5.10% |
| 1998-06-30 | 5.11% |
| 1997-06-30 | 5.03% |
| 1996-06-30 | 3.60% |
Related Metrics
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Jason Hollar